Skip to main content

Advertisement

Springer Nature Link
Log in

Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia

  • Original Articles
  • Published:
Blut Aims and scope Submit manuscript

Summary

In patients with severe aplastic anemia (SAA), lymphocyte subpopulations were examined for the presence of HLA-DR and 2H4 (suppressor/inducer subset) antigen-expressing cells by flow cytometric analysis. Investigations were performed on peripheral blood lymphocytes before and after therapy with antithymocyte globulin (ATG) and methylprednisolone (MP), as well as on bonemarrow lymphocytes before therapy. Before treatment, only the absolute numbers of CD4+ T cells and the CD4+HLA−DR+/CD8+HLA-DR+ activated T cell ratio were significantly decreased (p<0.01 and p<0.001, respectively). Following successful ATG/MP treatment, a decrease in the CD4+/CD8+T cell ratio was found. Regarding the suppressor/inducer subset, only absolute numbers of CD4+/2H4+ cells were somewhat higher in treated patients; the percentages were the same in all groups of patients. Studies performed on bonemarrow lymphocytes showed significantly decreased percentages of CD4+ and CD8+ T lymphocytes, which also express HLA-DR antigen. No significant changes in the distribution of activated T cells following ATG/MP therapy were found, suggesting that these cells play no major role in the pathogenesis of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bacigalupo A, Giordano D, Van Lint MT, Vimercati R and Marmont AM (1979) Bolus methylprednisolone in severe aplastic anemia. N Engl J Med 300: 501–502

    Google Scholar 

  2. Bacigalupo A, Podesta M, Frassini T, Piaggio G, Van Lint M, Raffe M, Repetto M, Marmont A (1982) Generation of CFU-C suppressor T cells in vitro. A multistep process. Br J Haematol 52: 421–427

    Google Scholar 

  3. Camitta B, O'Reilly RJ, Sensebrenner L, Rappeport J, Champlin R, Doney K, August C, Hoffmann RG, Kirkpatrick D, Stuart R, Santos G, Parkman R, Gale RP, Storb R, Nathan D (1983) Antithoracic duct lymphocyte globulin therapy of severe aplastic anemia. Blood 62: 883–888

    Google Scholar 

  4. Carney WP, Iaciviello V, Hirsch MS (1983) Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis. J Immunol 130: 390–393

    Google Scholar 

  5. Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308: 113–118

    Google Scholar 

  6. De Waele M, Thilemans C, Van Camp BK (1983) Immunoregulatory T cells in mononucleosis and toxoplasmosis. N Engl J Med 305: 228–232

    Google Scholar 

  7. De Waele M, Naessens A, Foulon W, Van Camp BK (1985) Activated T cells with suppressor/cytotoxic phenotype in acute toxoplasma gondii infection. Clin Exp Immunol 62: 256–261

    Google Scholar 

  8. Falcao RP, Voltarelli JC, Bottura CT (1985) T lymphocyte subpopulations in the peripheral blood and bone marrow of patients with aplastic anemia. Blut 50: 103–107

    Google Scholar 

  9. Fischer M, Lechner K, Hinterberger W, Niessner H, Pabinger I, Duczak R, Neumann E, Korninger C, Deutsch E (1985) Deficiency of fibrinogen and factor VIII following treatment of severe aplastic anemia with antithymocyte globulin and high-dose methylprednisolone. Scand J Haematol 34: 312–316

    Google Scholar 

  10. Freundlich B, Jimenez SA (1987) Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamin therapy. Clin Exp Immunol 69: 375–384

    Google Scholar 

  11. Gascon P, Zoumbus NC, Scala G, Djeu JY, Moore JG, Young NS (1985) Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of anti thymocyte globulin. Blood 65: 407–413

    Google Scholar 

  12. Gluckman E, Marmont A, Speck B, Gordon Smith (1984) Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation. Semin Hematol 21: 11–19

    Google Scholar 

  13. Hafler D, Fox DA, Manning ME, Schlossmann SF, Reinherz EL, Weiner H (1985) In vivo activated T lymphocytes in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. N Engl J Med 312: 1405–1411

    Google Scholar 

  14. Hinterberger W, Geissler K, Fischer M, Kabrna E, and Hoecker P (1985) Failure of identical twin bone marrow to restore haemopoiesis in two patients with severe aplastic anemia (SAA) without immunosuppression. Exp Haematol 13: [Suppl 17] 66

    Google Scholar 

  15. Hinterberger-Fischer M, Hinterberger W, Hoecker P, Schmidmeier W, Gadner H, Geissler K, Kos M, Schwarzinger I, Neumann E, Niessner W, Schindler J, Lechner K (1986) Treatment of severe aplastic anemia with combined immunosuppression (anti thymocyte globulin and high dose methyl-prednisolone). Acta Haematol 76: 196–201

    Google Scholar 

  16. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geibler K, Höcker P, Huber C, Kahls P, Knapp W, Köller U, Lechner K, Volc-Platzer B (1988) Further evidence for lymphokine overproduction in severe aplastic anemia. Blood 72: 266–272

    Google Scholar 

  17. Hokland P, Kernstrup G, Griffin JD, Ellegard J (1986) Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood 67: 898–902

    Google Scholar 

  18. Holter W, Majdic O, Liszka K, Stockinger H, Knapp W (1985) Kinetics of activation antigen expression by in vitro stimulated human T lymphocyts. Cell Immunol 90: 322–329

    Google Scholar 

  19. Huang AT, Mold NG, Zhang SF (1987) Antithymocyte globulin stimulates human haemopoietic progenitor cell. Proc Natl Acad Sci USA 84: 5942–5946

    Google Scholar 

  20. Hunter RF, Mold NG, Mitchell RB, Huang A (1985) Differentiation of normal bone marrow and HL 60 cells induced by antithymocyte globulin. Proc Natl Acad Sci USA 84: 4823–4827

    Google Scholar 

  21. Janossy G, Tidman N, Papageorgeou ES, Kung PC, Goldstein G (1981) Distribution of T lmyphocyte subsets in the human bone marrow and thymus. An analysis with monoclonal antibodies. J Immunol 126: 1608–1613

    Google Scholar 

  22. Kagan W, Ascenaso J, Pahwa R, Hansen R, Goldstein G, Valera G, Moore M, Good R (1976) Aplastic anemia: presence in human bone marrow of cells that suppress myelopoiesis. Proc Natl Acad Sci 3: 2890–2895

    Google Scholar 

  23. Koeller U, Majdic O, Liszka K, Stockinger H, Pabinger-Fasching I, Lechner K, Knapp W (1986) Lymphocytes of haemophilia patients treated with clotting factor concentrates display activation linked cell surface antigens. Clin Exp Immunol 59: 613–622

    Google Scholar 

  24. Kuriyama K, Tomonaga M, Jinnati I, Matsuo T, Yoshida Y, Ichimaru M (1984) Reduced helper (OKT4+): suppressor (OKT8+) T ratios in aplastic anemia: relation to immunosuppressive therapy. Br J Haematol 57: 329–336

    Google Scholar 

  25. Letvin NL, Morimoto G, Aldrich WR, Schlossman SF (1986) Definition of the T lymphocyte inducer of suppression in primates using a monoclonal antibody. Cell Immunol 94: 360–368

    Google Scholar 

  26. Morimoto C, Letvin NL, Distaso JA, Brown HM, Schlossman SF (1986) The cellular basis for the induction of antigen specific T8 suppressor cells. Eur J Immunol 16: 198–204

    Google Scholar 

  27. Morimoto C, Letvin NL, Distaso JA, Brown HM, Schlossman SF (1986) The isolation and characterization of the human suppressor inducer T cell subset. Eur J Immunol 16: 1508–1515

    Google Scholar 

  28. Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Dalez T, Levine H, Schlossman SF (1987) A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79: 762–768

    Google Scholar 

  29. Morimoto C, Hafler DA, Weiner HL, Letvin NL, Hagan M, Daley J, Schlossman SF (1987) Selective loss of the suppressor/inducer T cell subset in progressive multiple sclerosis. N Engl J Med 316: 67–72

    Google Scholar 

  30. Pitzalis K, Kingsley G, Murphy J, Panayi G (1987) abnormal distribution of the helper- inducer and suppressorinducer T lymphocyte subsets in the rheumatoid joint. Clin Immunol Immunopathol 45: 252–258

    Google Scholar 

  31. Platanias L, Gascon P, Bielory L, Zoumbos N, Djeu J, Siegel J, Nienhuis L and Young N (1985) Alternations in lymphocyte phenotype and lymphokines in patients with aplastic anemia following anti/ thymocyte glublin (ATG) therapy (abstract). Blood [Suppl] 66: 374

    Google Scholar 

  32. Platanias K, Gascon P, Bielory L, Griffith P, Nienhuis A, Young N (1987) Lymphocyte phenotype and lymphokines following anti-thymocyte globulin therapy in patients with aplastic anemia. Br J Haematol 66: 437–443

    Google Scholar 

  33. Reinherz EL, Kung PC, Pesandro JM, Ritz G, Goldstein G, Schlossman SF (1979). Ia determinants on human T cells defined by monoclonal antibody: activation stimuli required for expression. J Exp Med 150: 1472–1477

    Google Scholar 

  34. Schober I, Braun R, Reiser H, Munk K, Leroux M, Kirchner H (1984) Ia- positive T lymphocytes are the producer cells of interferon gamma. Exp cell Res 152: 348–355

    Google Scholar 

  35. Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burri HP, Cornn P, Jeannet M (1981) Treatment of severe aplastic anemia with anti lymphocyte globuline or bone marrow transplantation. Br Med J 281: 860–863

    Google Scholar 

  36. Speck B, Gratwohl A, Nissen C, Osterwalder B, Wursch A, Tichelli A, Lori A, Reusser P, Jeannet M, Signer E (1986) Treatment of severe aplastic anemia. Exp Hematol 14: 126–132

    Google Scholar 

  37. Stockinger H, Majdic O, Liszka Ch, Koeller U, Holter W, Peschel C, Bettelheim P, Gisslinger H, Knapp W (1986) T 14, a non modulating 150 KD T cell antigen. In: Reinherz E, Haynes BF, Nadler LM, Bernstein ID (eds) Leukocyte typing II, vol 1. Springer, Berlin Heidelberg New York, pp 513–524

    Google Scholar 

  38. Sullivan R, Quesenberry P, Parkman R, Zuckermann KS, Levey RH, Rappaport J, Ryan M (1980) Aplastic anemia: lack of bone marrow lymphocytes on in vitro granulopoiesis. Blood 56: 625–630

    Google Scholar 

  39. Torok-Storb BJ, Sieff C, Storb R, Admason J, Thomas ED (1980) In vitro tests for distinguishing possible immune mediated aplastic anemia identified by microfluorometry. Blood 55: 211–215

    Google Scholar 

  40. Torok Storb BJ, Donez K, Sale G, Thomas Ed, Storb R (1985) Subsets of patients with aplastic anemia identified by microfluorometry. N Engl J Med 312: 1015–1022

    Google Scholar 

  41. Zu DTY, Winchester RJ, Fu SM, Gibovsky A, Ko HS, Kunkel HG (1980) Peripheral blood Ia positive T cells: increases in certain diseases and after immunization. J Exp Med 151: 91–99 Semin Hematol 21: 11–19

    Google Scholar 

  42. Zoumbos NC, Ferris WO, Hsu SM, Goodmans S, Griffith P, Sharrow SO, Humphries KR, Nienhuis AW, Young N (1984) Analysis of lymphocyte subsets in patients with aplastic anemia. Br J Haematol 58: 95–105

    Google Scholar 

  43. Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young N (1985) circulating activated suppressor lymphocytes in aplastic anemia. N Engl J Med 312: 257–264

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Chemistry and Laboratory Diagnostics, University of Vienna, Lazarettgasse 14, A-1090, Vienna, Austria

    U. Köller

  2. Department of Haematology, 1st Department of Internal Medicine, University of Vienna, A-1090, Vienna, Austria

    W. Hinterberger

  3. Institute of Immunology, University of Vienna, A-1090, Vienna, Austria

    L. Gschwandtler, O. Majdic & W. Knapp

  4. St. Anna Children Hospital, A-1090, Vienna, Austria

    R. Grümayer

Authors
  1. U. Köller
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. W. Hinterberger
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. L. Gschwandtler
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. R. Grümayer
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. O. Majdic
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. W. Knapp
    View author publications

    You can also search for this author inPubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Köller, U., Hinterberger, W., Gschwandtler, L. et al. Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia. Blut 58, 21–26 (1989). https://doi.org/10.1007/BF00320231

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00320231

Key words